Key Takeaways From GlaxoSmithKline's Third-Quarter Earnings
British Pharma GlaxoSmithKline reported third-quarter earnings this morning. Here's what you need to know.
Why Biogen Idec Stock Shares Are Getting Pummeled Today
Biogen Idec shares tumbled more than 10% today on news that a Tecfidera patient was diagnosed with a rare brain disease.
Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?
This Drug Could Outsell Medical Marijuana
Three top motley fool analysts weigh in on drugs from Gilead Sciences, Biogen, Bristol-Myers, and Merck that could be bigger sellers than medical marijuana.